Finance

Lists
600518:SHA
Kangmei Pharmaceutical Co Ltd
1,30 CNY
+0,78%
(+0,0100) 1D
16 ოქტ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600518...
Open
1,30 CNY
High
1,33 CNY
Low
1,29 CNY
Mkt. cap
17,98 მლრდ.
Avg. vol.
141,12 მლნ.
Volume
120,66 მლნ.
P/E ratio
375,72
52-wk high
2,16 CNY
52-wk low
1,16 CNY
EPS
0,00 CNY
Shares outstanding
4,93 მლრდ.
No. of employees
5 ათ.
Open
1,30 CNY
High
1,33 CNY
Low
1,29 CNY
Mkt. cap
17,98 მლრდ.
Avg. vol.
141,12 მლნ.
Volume
120,66 მლნ.
P/E ratio
375,72
52-wk high
2,16 CNY
52-wk low
1,16 CNY
EPS
0,00 CNY
Shares outstanding
4,93 მლრდ.
No. of employees
5 ათ.
News stories
From web sources and news partners
About Kangmei Pharmaceutical Co Ltd
CEO-
Employees5,49 ათ.
Founded18 ივნ. 1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,38 მლრდ.
1,29 მლრდ.
1,08 მლრდ.
1,21 მლრდ.
Cost of goods sold
1,11 მლრდ.
1,10 მლრდ.
841,45 მლნ.
969,13 მლნ.
Cost of revenue
1,11 მლრდ.
1,10 მლრდ.
841,45 მლნ.
969,13 მლნ.
Research and development expenses
14,78 მლნ.
12,64 მლნ.
9,66 მლნ.
4,01 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
274,41 მლნ.
285,59 მლნ.
237,06 მლნ.
253,72 მლნ.
Operating expense
247,81 მლნ.
418,70 მლნ.
253,80 მლნ.
264,03 მლნ.
Total operating expenses
1,36 მლრდ.
1,52 მლრდ.
1,10 მლრდ.
1,23 მლრდ.
Operating income
22,48 მლნ.
-225,20 მლნ.
-15,46 მლნ.
-22,45 მლნ.
Other non operating income
-48,58 მლნ.
83,13 მლნ.
-494,88 ათ.
-14,66 მლნ.
EBT including unusual items
2,07 მლნ.
12,52 მლნ.
-14,01 მლნ.
55,01 მლნ.
EBT excluding unusual items
1,42 მლნ.
-87,63 მლნ.
-12,62 მლნ.
43,62 მლნ.
Income tax expense
5,30 მლნ.
15,18 მლნ.
1,97 მლნ.
1,66 მლნ.
Effective tax rate
255,69%
121,26%
-14,09%
3,01%
Other operating expenses
2,71 მლნ.
24,90 მლნ.
2,56 მლნ.
17,29 მლნ.
Net income
-3,82 მლნ.
-2,75 მლნ.
-16,56 მლნ.
52,60 მლნ.
Net profit margin
-0,28%
-0,21%
-1,53%
4,34%
Earnings per share
-
-
-
-
Interest and investment income
29,35 მლნ.
68,16 მლნ.
4,62 მლნ.
81,94 მლნ.
Interest expense
-1,82 მლნ.
-13,72 მლნ.
-1,28 მლნ.
-1,20 მლნ.
Net interest expenses
27,53 მლნ.
54,44 მლნ.
3,34 მლნ.
80,73 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
92,91 მლნ.
-156,94 მლნ.
52,80 მლნ.
45,08 მლნ.
Gain or loss from assets sale
286,02 ათ.
-846,81 ათ.
-
-3,74 მლნ.
AI content may include mistakes. Learn more
Google აპები